Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.85, read 2026-10-28
Ethical does not pass the values gate
Price79.28 USD
Fair value143.84
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-10-11Read Accumulation77.57+2.2% to today ✓Markdown gives way to Accumulation
2026-10-02Read Markdown77.57+2.2% to today Accumulation gives way to Markdown after a 15% slide in 6 weeks
2026-08-20Read Accumulation90.94-12.8% to today Markdown gives way to Accumulation with results news in the headlines
2026-08-18Read Markdown90.94-12.8% to today ✓Distribution gives way to Markdown after a 7% rise in 7 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
PDD Holdings holds its Accumulation at $79.28. The statistical read favours the sellers, held for 50 days.
As held on the ledger · 2026-10-29
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 50 days
Price at the screen
$79.28
Valuation
8.92 trailing · 6.41 forward price to earnings
Values screen
FAIL· score 10.0
Beta
-0.05
The Workings
Five Screens, Shown in Full
Does not pass. Revenue purity 5.9%
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
0.85%
Below 33%
Interest-bearing debt is just 0.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
17.28%
Below 33%
Cash held in interest-bearing accounts and securities is 17.3% of assets, under the one-third limit.
Pass
Receivables
0.81%
Below 49%
Money owed to the company is 0.8% of assets, under the 49% limit.
Pass
Revenue purity
5.92%
Below 5%
5.9% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
PDD clears the business-activity screen, and its debt is near-nil. Where it falls short is income purity: around 6% of its income right now is interest earned on a large cash position, against a roughly 5% ceiling, so it does not pass. That reflects what it earns today, not the business itself, and it could clear the screen if its operating revenue grows and the interest share falls.
Read as at 2026-10-30. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PDD's ethical verdict changes
Today PDD does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades at roughly a 81% discount to our $143.84 fair value, 8.10% revenue growth.
Fair value range in USD, drawn from the 2026-10-29 screen. The gold marker is the market price at the same screen. A 81.4% margin of safety to the base estimate.
Third-party analyst targets: 33 covering, consensus Buy. The average target sits +45% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-29 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Pinduoduo's Ethical Flaws Outweigh Market Value
Imagine every time you log onto Pinduoduo or Temu, you're contributing to a platform that's ethically lacking. That's the case with PDD Holdings, which despite its flashy interface and user engagement, fails our ethical screen - a critical factor for us at Titan Protect. This multinational commerce group's operations include the popular Pinduoduo platform, offering a wide array of products and shopping experiences, alongside Temu, an online marketplace for merchants.
Why it stands out, or rather, why we pass - the numbers are compelling on the surface. PDD Holdings boasts a forward P/E of 7.3x, which looks like a steal compared to the market, a revenue growth of 11%, and a profit margin of 22%. ROE is a respectable 25%, and the market consensus is a resounding buy with a median target of $116. Yet, the ethical failings cast a shadow over these figures, as revenue purity is a mere 5.9%, indicating a significant portion of the business may not align with our ethical standards.
Risk here is twofold: first, the ethical misalignment that leads us to avoid this opportunity, and second, the cyclical nature of the business which, while showing growth, could be a peak earnings trap with the low P/E. The market is currently valuing PDD Holdings at $89.52, well below our fair value of $144.91, indicating a substantial margin of safety. However, when ethics are non-negotiable, even a seemingly good deal must be passed over. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Ireland and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PDD trades on NASDAQ (the company is based in Ireland). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Accumulation$82.42+0.0%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $115.
2026-10-18Accumulation$82.42+6.3%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (34 analysts) rates it buy, with a mean price target of $115.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (34 analysts) rates it buy, with a mean price target of $115.
2026-10-02Markdown · changed$77.57-13.3%Entry 13
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 13.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (34 analysts) rates it buy, with a mean price target of $115.
2026-08-25Accumulation$89.52+0.0%Entry 12
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (34 analysts) rates it buy, with a mean price target of $117. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Accumulation$89.52+0.0%Entry 11
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-23Accumulation$89.52+0.0%Entry 10
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-22Accumulation$89.52+0.0%Entry 9
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-21Accumulation$89.52-1.6%Entry 8
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
